Swift Coil System 400SWPC25-ARecalls & reported problems
Penumbra, Inc. · SwiftPAC Coil, 25 cm · Class 2 · Implant
All models of Swift Coil System (11)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00815948029682), received between Jan 30, 2026 and Jan 30, 2026 — classified as 1 malfunction.
The most frequently reported specific device problem is “Migration” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Migration1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 30, 2026Migration
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE BILATERAL MIDDLE MENINGEAL ARTERIES (MMA) USING SWIFTPAC COILS (SWIFTPAC), A SWIFT COIL DETACHMENT HANDLE, MIDWAY 43 DELIVERY CATHETER (MIDWAY 43), AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN DETACHED FOUR SWIFTPACS IN THE RIGHT MMA USING THE HANDLE. THE PHYSICIAN THEN ADVANCED A FIFTH SWIFTPAC TO THE TARGET LOCATION AND ATTEMPTED TO DETACH IT USING THE HANDLE; HOWEVER, THE SWIFTPAC COIL DID NOT DETACH. THE PHYSICIAN SUBSEQUENTLY USED HEMOSTATS TO MANUALLY DETACH THE COIL. THE PHYSICIAN PLACED THREE SWIFTPAC COILS IN THE LEFT MMA USING THE MICROCATHETER AND MIDWAY 43. A FOURTH SWIFTPAC WAS THEN SUCCESSFULLY DETACHED AT THE TARGET LOCATION. AFTER REMOVAL OF THE MICROCATHETER FROM THE TARGET VESSEL, THE SWIFTPAC COIL WAS OBSERVED TO BE WITHIN THE MIDWAY 43 CATHETER. THE MIDWAY 43 CONTAINING THE DETACHED COIL WAS THEN REMOVED FROM THE PATIENT. IT WAS REPORTED THAT A PORTION OF THE COIL MAY HAVE BEEN WITHIN THE MICROCATHETER AT THE TIME OF DETACHMENT, AND THAT REMOVAL OF THE MICROCATHETER MAY HAVE CONTRIBUTED TO MOVEMENT OF THE COIL INTO THE MIDWAY 43. IT WAS ALSO REPORTED THAT THE MIDWAY 43 CATHE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24226658 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page